-
2024-515883-30-00
6
2024-08-01
St-Elevated Myocardial Infartion
-
2022-502135-19-00
4
2024-07-18
Calcific Aortic Valve Stenosis
-
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
-
2022-502956-29-00
5
2024-07-01
Oligometastatic prostate cancer (OMPC)
-
2023-503219-14-01
10
2024-05-22
systemic sclerosis associated interstitial lung disease
-
2023-505929-14-00
5
2024-05-21
Systemic Lupus Erythematosus
-
2023-504044-34-00
4
2024-04-17
Untreated Chronic Lymphocytic Leukemia
-
2023-504865-21-00
5
2024-04-15
Essential Thrombocythemia patients who have an inadequate response to
-
2023-509793-38-00
4
2023-11-24
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or CLL-like mo
-
2023-503661-28-00
5
2023-10-26
Hidradenitis Suppurativa
-
2023-510431-11-00
4
2023-07-21
Chronic Lymphocytic Leukemia
-
2024-517942-33-03
5
2023-02-04
cardiac amyloidosis
-
2023-510240-20-00
4
2022-10-05
Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
-
2023-508879-36-00
5
2022-04-28
Pruritus
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-518962-29-00
4
2021-12-07
Spinocerebellar ataxia type 7 (SCA7)
-
2023-510515-19-00
5
2020-11-27
Higher-risk-myelodysplastic syndromes
-
2023-510433-29-00
5
2020-09-24
Favorable-intermediate-risk Acute Myeloid Leukemia
-
2023-505901-17-00
5
2020-04-24
Acute Myeloid Leukemia (LMA) with FLT3 mutation
-
2023-508956-20-00
5
2020-03-12
Hidradenitis suppurativa
-
2023-510516-39-00
4
2019-10-30
Acute B-cell Lymphoblastic Leukemia with minimal residual positive dis
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2024-513282-39-00
5
2025-05-28
Hidradenitis Suppurativa (HS)